𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stimulation of myelin gene expression in vitro and of sciatic nerve remyelination by interleukin-6 receptor–interleukin-6 chimera

✍ Scribed by S. Haggiag; P.-L. Zhang; G. Slutzky; V. Shinder; A. Kumar; J. Chebath; M. Revel


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
450 KB
Volume
64
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Induction of myelin gene expression denotes the last stage of differentiation of myelinating glial cells. Following peripheral nerve transection, Schwann cells (SC) lose myelin gene expression and proliferate, resembling premyelinating embryonic SC (eSC). We show that a fusion protein of the soluble interleukin‐6 receptor to interleukin‐6 (IL6RIL6), a potent activator of the gp130 signaling receptor, is an inducer of MBP and Po gene products in rat E18 embryonic dorsal root ganglia (DRG) 3 day cultures. Cells whose growth is dependent on the IL6RIL6 chimera were isolated from DRG. These cells (designated CH cells) express Krox‐20, as do promyelinating and myelinating SC (mSC). IL6RIL6 induces Po and MBP in CH cells and their cocultures with neurons. In addition, IL6RIL6 leads to a disappearance of Pax‐3, a marker of eSC and nonmyelinating Schwann cells (nmSC). Glial fibrillary acidic protein, present in nmSC, is not significantly induced by IL6RIL6. The CH cells acquire glial morphology when exposed to IL6RIL6 and cover axons in cocultures. In a sciatic nerve‐derived SC line, IL6RIL6 also induces Po and triggers a rapid attachment along axons. In vivo administration of IL6RIL6 intraperitoneally to rats after sciatic nerve transection and resuture increases 4‐fold the number of myelinated nerve fibers (MF) measured on day 12, 2.5–5 mm distal to the suture. The stimulation by IL6RIL6 treatment is highest (7.1‐fold) at the more distant 5 mm site, and the thickness of myelin sheaths is increased. Compared to known SC growth factors, the gp130 activator IL6RIL6 appears to combine both in vitro mitogenic effects and promotion of myelin gene expression. J. Neurosci. Res. 64:564–574, 2001. © 2001 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


INTERLEUKIN-6-INDUCED PRODUCTION OF TYPE
✍ Beata Derfalvi; Peter Igaz; Kristof A Fulop; Csaba Szalai; Andras Falus 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 222 KB

## Abstract Growth hormone (GH), given therapeutically in many human diseases, is able to modulate the maturation and function of many cells of immune system. The present study demonstrates the effect of human recombinant GH on the production of acute phase proteins (APP) as well as on the gene exp

MicroRNA-dependent regulation of DNA met
✍ Chiara Braconi; Nianyuan Huang; Tushar Patel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB

Although the inflammation-associated cytokine interleukin-6 (IL-6) has been implicated in cholangiocarcinoma growth, the relationship between IL-6 and oncogenic changes is unknown. IL-6 can increase expression of DNA methyltransferase-1 (DNMT-1) and epigenetically regulate the expression of several

Regulation of gene expression by interle
✍ Cesar Roncero; Isabel Fabregat; Dr Manuel Benito 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 901 KB

Fetal rat hepatocytes incubated in the absence of hormonal signals, or under proliferative (presence of epidermal growth factor [EGF]) or differentiative (presence of dexamethasone) culture conditions, showed responsiveness to interleukin-6 (IL-6). Northern blotting analysis for some typical acute p

Selective estrogen receptor modulators d
✍ M. Cerciat; M. Unkila; L. M. Garcia-Segura; M.-A. Arevalo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

## Abstract Expression of proinflammatory molecules by glial cells is involved in the pathophysiological changes associated with chronic neurological diseases. Under pathological conditions, astrocytes release a number of proinflammatory molecules, such as interleukin‐6 (IL‐6) and interferon‐γ‐indu